4.5 Article

The Path(way) Less Traveled: A Pathway-Oriented Approach to Providing Information about Precision Cancer Medicine on My Cancer Genome

Journal

TRANSLATIONAL ONCOLOGY
Volume 9, Issue 2, Pages 163-165

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.tranon.2016.03.001

Keywords

-

Categories

Funding

  1. Edward P. Evans Foundation
  2. Joyce Family Foundation
  3. GenomOncology
  4. Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
  5. T. J. Martell Foundation
  6. National Institutes of Health
  7. National Cancer Institute [R01CA121210, P01CA129243]
  8. Damon Runyon Clinical Investigator Award
  9. LUNGevity Career Development Award

Ask authors/readers for more resources

This perspective describes the motivation, development, and implementation of pathway-based content for My Cancer Genome, an online precision medicine knowledge resource describing clinical implications of genetic alterations in cancer. As researchers uncover more about cancer pathogenesis, we are learning more not only about the specific genes and proteins involved but also about how those genes and proteins interact with others along cell signaling pathways. This knowledge has led researchers and clinicians to begin to think about cancer therapy using a pathway-based approach. To facilitate this approach, My Cancer Genome used a list of more than 800 cancer-related genes to identify 20 cancer-relevant pathways and then created content focused on demonstrating the therapeutic relevance of these pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available